Introduction
Analysis of urine for drugs of abuse is commonplace in many clinical laboratories,' the main emphasis in the U.K., as elsewhere, being on narcotics, amphetamines, and barbiturates. '4 From time to time, however, other drugs, such as methaqualone,5 assume importance. Thin-layer chromatography constitutes the methodological basis of most drug-detection systems, but latterly immunoassay techniques have become important.6
Until recently no method of urine analysis was available for detecting cannabis use. Thus there is a dearth of reliable data on which to base present and future legislative policy regarding this drug. The A total of 475 specimens were analysed. Of these, 82 were from hospital inpatients in whom drug abuse was not (and never had been) queried but in whom a quantitative measurement of urinary steroids, catecholamines, or some other endogenous product had beenrequested for diagnostic purposes; 319 came from two hospital treatment clinics (A and B) and one independent drug treatment clinic (C), for all of which the West Park Hospital laboratory provides a routine service for the analysis of drugs in urine;'0 and 74 came from other sources, including general medical outpatient departments, psychiatric clinics, and general practitioners' surgeries, with a request for routine analysis for drugs. This last, miscellaneous group included 17 specimens from eight residents of a hostel for former drug addicts. A condition for entry to and continued residence at the hostel is complete abstinence from habit-forming drugs, and to ensure compliance with this rule urine samples are tested regularly for narcotics, amphetamines, and barbiturates.
For this investigation urine samples containing less than 10 /tg of THC-CRC per 1 of urine were regarded as negative. More than a third of the samples from the drug treatment clinics came from patients who provided two or more specimens.
Results
All 82 urine specimens from the hospital inpatients were negative for cannabis (see fig.) . Of the 162 specimens from clinic A and the 50 from clinic B 51 (31%) and 19 (380%), respectively, were positive for THC-CRC; 71 (66%') of the 107 specimens from clinic C contained THC-CRC, as did 13 (18%) of the 74 "miscellaneous" specimens.
Investigation into the origin of the THC-CRC-positive specimens in the miscellaneous group disclosed that six of them came from the rehabilitation hostel and were provided by three people.
Altogether 0  123  16  19  19  46  17  76  0  0  18  0  0  0  19  96  20  650  20  26  24  6  21  18   0  5  22  0  0  0  23  350  510  550  24  660  66  84  25  30  25  10  12  0  26  150  160  117   27  14  48  0  28  0  5  21  97  29  14  0  0  0  30  0  0  0  31  16  22  5  32  107  1070  91 major metabolite 11-hydroxy-THC, which is equally psychoactive. Hitherto, attempts to detect and measure cannabis derivatives in blood and urine have been either unsuccessful or so tedious, expensive, and technically demanding'3 14 as to be quite impracticable except for small-scale research investigations. A radioimmunoassay for THC-CRC of different sensitivity and specificity to our own has been described in preliminary form by Gross et al."5
Estimates of the frequency of cannabis use among known narcotics users in the U.K. made by several groups1 6-19 on the basis of personal histories, which are notoriously unreliable in such patients, without objective assessment have ranged from 86% to 100%. These estimates are much higher than were actually observed and may represent the difference between sporadic and more or less constant use. The rate of cannabis use in our study was similar in patients attending the two hospital treatment clinics but was substantially higher in patients attending the independent clinic, at which treatment with narcotics, especially heroin and methadone, is specifically avoided.
The rate of cannabis use as shown by urine analysis in patients suspected of but not necessarily admitting to misusing drugs was 10%. The relatively high rate-3 out of 8 patients, and 6 out of 17 urine specimens-of cannabis use by "rehabilitated" narcotics users living in a hostel was unsuspected. The concentration of a drug in the urine is at best a poor guide to the amount actually taken, since a low concentration can be the result of either a large dose taken a long time previously or a small dose taken a short time previously. Nevertheless, the wide range of values for urinary THC-CRC concentrations observed (nil to over 1500 jig/l) lends credence to the suggestion by Fairbairn et al.20 that the daily cannabis intake may vary by more than a hundredfold among persons admitting to using the drug.
The quantitative urine analysis data appeared ( fig.) to reveal two populations among the patients attending the drug dependence clinics-those who use a lot of cannabis and thus excrete large amounts of THC-CRC in their urine, and those who abstain from cannabis completely. This concept gained support when the data on the 32 individual patients from whom multiple samples were obtained and examined. There was an unmistakable tendency (admittedly not absolute) for the specimens from one patient to be either all negative or all positive, though the actual concentration of THC-CRC might vary considerably. Clearly more extensive investigation is necessary before firm conclusions concerning the prevalence ofcannabis useamong drug-dependent persons and others can be drawn. Nevertheless, it seems reasonable to suppose that radioimmunoassay could provide the objective basis for such study.
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